# A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis

> **NCT01126619** · — · COMPLETED · sponsor: **Abbott** · enrollment: 103 (actual)

## Conditions studied

- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01126619
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2012-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01126619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01126619, "A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01126619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*